Pharming Group N.V. (PHAR) Revenue 2019–2025
Pharming Group N.V. (PHAR) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$376.1MFY2025 · since FY2019: $189.4M → $376.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $376.1M | +26.6% |
| FY2024 | $297.2M | +21.1% |
| FY2023 | $245.3M | +19.3% |
| FY2022 | $205.6M | +3.4% |
| FY2021 | $198.9M | -6.3% |
| FY2020 | $212.2M | +12.0% |
| FY2019 | $189.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice